These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-001426-24||Multicenter, open, randomized study for first-line treatment of multiple myeloma: thalidomide/dexamethasone vs. MP for induction therapy and thalidomide/Intron A vs. Intron A for maintenance therapy||2009-08-30||due-trials|
|Not reported||2009-013706-13||ANALGESIC RESPONSE TO TRANSDERMAL LIDOCAINE IN PATIENTS WITH PAINFUL PERIPHERAL DIABETIC NEUROPATHY UNDERLYING DIFFERENT SENSORY PATTERNS||2014-06-01||due-trials|
|Not reported||2012-001420-35||The effect of a single skin treatment with Capsaicine 8% in low back pain||2015-02-02||due-trials|
|Not reported||2015-003208-22||Does a two-day pretreatment with capsaicin reduce postoperative hyperalgesia and pain in surgical patients||2016-03-09||due-trials|
|Not reported||2015-004097-15||A single center, prospective, randomized, double blind, placebo-controlled, three-way cross-over study of the analgesic effects of Midazolam versus Placebo with Fentanyl as an active control in human ...||2016-03-09||due-trials|
|Ongoing||2015-004517-24||A prospective, open-label, proof-of-concept pilot study of the effects of a single one-hour target-controlled remifentanil infusion on pain in 24 patients with persistent postsurgical pain.||not-yet-due|